Skip to main content Accessibility help
×
Home

Using data linkage methodologies to augment healthcare-associated infection surveillance data

  • Seungwon Lee (a1), Paul Ronksley (a1) (a2), John Conly (a3) (a4) (a2) (a5), Stephanie Garies (a1) (a6), Hude Quan (a1) (a2), Peter Faris (a7), Bing Li (a7) and Elizabeth Henderson (a1)...

Abstract

Background and objectives:

The landscape of antimicrobial resistance (AMR) surveillance is changing rapidly. The primary objective of this study was to assess the benefit of linking population-based infection prevention and control surveillance data on methicillin-resistant Staphylococcus aureus (MRSA) to hospital discharge abstract data (DAD). We assessed the value of this novel data linkage for the characterization of hospital-acquired (HA) and community-acquired MRSA (CA-MRSA) cases.

Methods:

Incident inpatient MRSA surveillance data for all adults (≥18 years) from 4 acute-care facilities in Calgary, Alberta, between April 1, 2011, and March 31, 2017, were linked to DAD. Personal health number (PHN) and gender were used to identify specific individuals, and specimen collection time-points were used to identify specific hospitalization records. A third common variable on admission date between these databases was used to validate the linkage process. Descriptive statistics were used to characterize HA-MRSA and CA-MRSA cases identified through the linkage process.

Results:

A total of 2,430 surveillance records (94.6%) were successfully linked to the correct hospitalization period. By linking surveillance and administrative data, we were able to identify key differences between patients with HA- and CA-MRSA. These differences are consistent with previously reported findings in the literature. Data linkage to DAD may be a novel tool to enhance and augment the details of base surveillance data.

Conclusion and recommendations:

This is the first Canadian study linking a frontline healthcare-associated infection AMR surveillance database to an administrative population database. This work represents an important methodological step toward complementing traditional AMR surveillance data practices. Data linkage to other data types, such as primary care, emergency, social, and biological data, may be the basis of achieving more precise data focused around AMR.

Copyright

Corresponding author

Author for correspondence: Dr Elizabeth Henderson, Email: ehenders@ucalgary.ca.

Footnotes

Hide All

PREVIOUS PRESENTATION. This study was presented at the 2018 International Population Data Linkage Conference on September 13, 2018, in Banff, Alberta, Canada.

Footnotes

References

Hide All
1. Wilson, APR, Livermore, DM, Otter, JA, et al. Prevention and control of multi-drug-resistant gram-negative bacteria: recommendations from a Joint Working Party. J Hosp Infect 2016;92:S1S44.
2. Vasoo, S, Barreto, JN, Tosh, PK. Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician. Mayo Clin Proc 2015;90:395403.
3. Tornimbene, B, Eremin, S, Escher, M, Griskeviciene, J, Manglani, S, Pessoa-Silva, CL. WHO global antimicrobial resistance surveillance system early implementation. Lancet Infect Dis 2018;18:241242.
4. WHO publishes list of bacteria for which new antibiotics are urgently needed. World Health Organization website. https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Published 2017. Accessed March 16, 2018.
5. Antibiotic/antimicrobial resistance (AR/AMR)—biggest threats and data. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/biggest_threats.html. Published 2018. Accessed April 14, 2019.
6. Amaratunga, K, Tarasuk, J, Tsegaye, L, Archibald, CP. Advancing surveillance of antimicrobial resistance: summary of the 2015 CIDSC report. Can Commun Dis Rep 2016;42:232237.
7. Drees, M, Gerber, JS, Morgan, DJ, Lee, GM. Research methods in healthcare epidemiology and antimicrobial stewardship: use of administrative and surveillance databases. Infect Control Hosp Epidemiol 2016;37:12781287.
9. Provincial wide surveillance. Alberta Health Services website. https://www.albertahealthservices.ca/assets/healthinfo/ipc/hi-ipc-provincial-surveillance.pdf. Published 2018. Accessed March 17, 2018.
10. Methicillin-resistant Staphylococcus aureus (MRSA) culture. Calgary Laboratory Services website. http://www.calgarylabservices.com/lab-services-aguide/microbiology/Test/Tests/MethicillinResistantStaphylococcusAureusMRSA.aspx. Published 2018. Accessed October 22, 2018.
11. Discharge abstract database (DAD) metadata. Canadian Institute for Health Information website. https://www.cihi.ca/en/discharge-abstract-database-metadata. Published 2018. Accessed April 5, 2018.
12. Alberta health care insurance plan (AHCIP). Government of Alberta website. https://www.alberta.ca/ahcip.aspx. Published 2019. Accessed April 6, 2019.
13. Naimi, TS, LeDell, KH, Como-Sabetti, K, et al. Comparison of community and health care–associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:29762984.
14. Morrison, MA, Hageman, JC, Klevens, RM. Case definition for community-associated methicillin-resistant Staphylococcus aureus. J Hosp Infect 2006;62:241.
15. MRSA: information for clinicians. Centers for Disease Control and Prevention website. https://www.cdc.gov/mrsa/community/clinicians/index.html. Published 2016. Accessed April 5, 2018.
16. Methicillin-resistant Staphylococcus aureus (MRSA) provincial surveillance protocol. Alberta Health Services website. https://www.albertahealthservices.ca/assets/healthinfo/ipc/hi-ipc-sr-mrsa-surveillance-protocol.pdf. Published 2018. Accessed April 5, 2018.
17. Andreassen, AES, Jacobsen, CM, de Blasio, BF, White, R, Kristiansen, IS, Elstrøm, P. The impact of methicillin-resistant S. aureus on length of stay, readmissions and costs: a register based case-control study of patients hospitalized in Norway. Antimicrob Resist Infect Control 2017;6:74.
18. Quan, H, Sundararajan, V, Halfon, P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:11301139.
19. Tackling antimicrobial resistance and antimicrobial use: a pan-Canadian framework for action. Government of Canada website. https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/tackling-antimicrobial-resistance-use-pan-canadian-framework-action.html#a3.1. Published 2017. Accessed April 6, 2018.
20. Dusetzina, SB, Tyree, S, Meyer, AM, et al. Linking data for health services research: a framework and instructional guide, an overview of record linkage methods. Agency for Healthcare Research and Quality (US) website. https://www.ncbi.nlm.nih.gov/books/NBK253312/. Published 2014. Accessed April 6, 2019.
21. Virnig, BA, McBean, M. Administrative data for public health surveillance and planning. Annu Rev Public Health 2001;22:213230.
22. Lukovac, E, Koluder-Cimic, N, Hadzovic-Cengic, M, Baljic, R, Hadzic, A, Gojak, R. Analysis of comorbidity of the patients affected by Staphylococcal bacteremia/sepsis in the last ten years. Materia Socio Medica 2012;24:13.
23. Campbell, KM, Vaughn, AF, Russell, KL, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California; 2002. J Clin Microbiol 2004;42:40504053.
Type Description Title
WORD
Supplementary materials

Lee et al. supplementary material
Tables S1-S3 and Figures S1-S2

 Word (186 KB)
186 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed